Unlocking the Potential: Eltrombopag Olamine in Thrombocytopenia Treatment
NINGBO INNO PHARMCHEM CO.,LTD. is proud to present a comprehensive look at Eltrombopag Olamine, a compound that has significantly advanced the treatment of various hematological disorders. As a leading supplier in the pharmaceutical chemical sector, we are dedicated to providing high-quality APIs and intermediates that drive medical innovation.
Eltrombopag Olamine, identified by its CAS number 496775-62-3, is a non-peptide, orally active agonist of the thrombopoietin receptor (TPO-R). This means it directly stimulates the bone marrow to produce more platelets. This mechanism of action makes it invaluable for patients suffering from conditions where low platelet counts are a major concern.
One of the primary eltrombopag olamine pharmaceutical applications is in the treatment of chronic immune thrombocytopenia (ITP). For patients who do not respond adequately to corticosteroids or splenectomy, Eltrombopag Olamine offers a vital alternative, helping to raise platelet counts and reduce the risk of bleeding. The effectiveness of eltrombopag olamine for immune thrombocytopenia has been well-documented in numerous clinical studies, solidifying its place in treatment protocols.
Furthermore, Eltrombopag Olamine plays a critical role in managing thrombocytopenia in patients with chronic hepatitis C. By increasing platelet counts, it enables these patients to safely initiate and continue interferon-based antiviral therapy, which is crucial for their overall health outcomes. The clinical trials exploring eltrombopag olamine efficacy in this context have shown promising results, highlighting its supportive role in managing complex medical conditions.
The compound is also a cornerstone in the treatment of severe aplastic anemia. For individuals whose bone marrow has a reduced ability to produce blood cells, Eltrombopag Olamine, when used in combination with standard immunosuppressive therapy, has demonstrated the ability to restore trilineage hematopoiesis – the production of red blood cells, white blood cells, and platelets. The eltrombopag olamine for aplastic anemia treatment has transformed the prognosis for many patients.
For those looking to buy eltrombopag olamine, understanding its chemical properties, such as its appearance as a white crystalline powder and its high purity (often exceeding 99%), is important. Sourcing Eltrombopag Olamine from a reputable eltrombopag olamine supplier like NINGBO INNO PHARMCHEM CO.,LTD. ensures product quality and consistency, which are paramount in pharmaceutical applications. The competitive eltrombopag olamine price also makes it accessible for a wider range of medical needs.
In conclusion, Eltrombopag Olamine is more than just a chemical compound; it is a therapeutic agent that offers significant benefits to patients worldwide. Its role as a thrombopoietin receptor agonist, its applications in critical hematological conditions, and its ongoing research underscore its importance in modern medicine. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to supplying this vital pharmaceutical intermediate, supporting advancements in healthcare.
Perspectives & Insights
Alpha Spark Labs
“Eltrombopag Olamine, identified by its CAS number 496775-62-3, is a non-peptide, orally active agonist of the thrombopoietin receptor (TPO-R).”
Future Pioneer 88
“This mechanism of action makes it invaluable for patients suffering from conditions where low platelet counts are a major concern.”
Core Explorer Pro
“One of the primary eltrombopag olamine pharmaceutical applications is in the treatment of chronic immune thrombocytopenia (ITP).”